Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review.
Journal: Blood cancer journal
Published: September 10, 2023
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review.
Journal: European journal of haematology
Published: May 29, 2023
Refractoriness to last line of therapy: how often is it mandated and reported? A systematic review of randomized myeloma trials.
Journal: Leukemia & lymphoma
Published: May 12, 2023
Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis.
Journal: Leukemia research
Published: March 29, 2023
Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies.
Journal: JCO global oncology
Published: August 12, 2022
Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis.
Journal: British journal of haematology
Published: July 26, 2022
Use of endpoints in multiple myeloma randomized controlled trials over the last 15 years: A systematic review.
Journal: American journal of hematology
Published: January 07, 2021
Quality of control groups in randomised trials of multiple myeloma enrolling in the USA: a systematic review.
Journal: The Lancet. Haematology
Published: November 23, 2020
Enrolment of racial minorities across 15 years of multiple myeloma randomised trials; calling on researchers to become agents of change.
Journal: The Lancet. Haematology
Published: July 08, 2020
Last Updated: 09/26/2026